Insmed annual net profit margin
2009
2010
2011
2013
2018
2019
2020
2021
2022
2023
2024
2025
Insmed Net Profit Margin Growth & History (INSM)
Insmed's net profit margin was −210.54% for fiscal 2025.
View full Insmed company overviewInsmed annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −210.54% | +40.70 pp |
| 2024 | 2024-12-31 | −251.24% | −5.65 pp |
| 2023 | 2023-12-31 | −245.59% | −49.33 pp |
| 2022 | 2022-12-31 | −196.26% | +34.38 pp |
| 2021 | 2021-12-31 | −230.63% | −51.76 pp |
| 2020 | 2020-12-31 | −178.87% | +7.50 pp |
| 2019 | 2019-12-31 | −186.37% | +3110.80 pp |
| 2018 | 2018-12-31 | −3,297.17% | — |
| 2013 | 2013-12-31 | −487.59% | — |
| 2011 | 2011-12-31 | −1,350.78% | −1257.82 pp |
| 2010 | 2010-12-31 | −92.96% | −1233.91 pp |
| 2009 | 2009-12-31 | 1,140.94% | — |
Insmed quarterly net profit margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q2.13
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −3.11% | +296.37 pp |
| Q1 2026 | 2026-03-31 | −53.46% | +222.96 pp |
| Q4 2025 | 2025-12-31 | −124.50% | +101.03 pp |
| Q3 2025 | 2025-09-30 | −259.95% | −23.91 pp |
| Q2 2025 | 2025-06-30 | −299.48% | +33.27 pp |
| Q1 2025 | 2025-03-31 | −276.42% | −68.35 pp |
| Q4 2024 | 2024-12-31 | −225.53% | −3.22 pp |
| Q3 2024 | 2024-09-30 | −236.04% | −35.05 pp |
| Q2 2024 | 2024-06-30 | −332.75% | −15.76 pp |
| Q1 2024 | 2024-03-31 | −208.07% | +36.92 pp |
| Q4 2023 | 2023-12-31 | −222.31% | +47.71 pp |
| Q3 2023 | 2023-09-30 | −201.00% | −7.37 pp |
| Q2 2023 | 2023-06-30 | −316.99% | −170.34 pp |
| Q1 2023 | 2023-03-31 | −244.98% | −66.81 pp |
| Q4 2022 | 2022-12-31 | −270.02% | −68.72 pp |
| Q3 2022 | 2022-09-30 | −193.63% | +47.43 pp |
| Q2 2022 | 2022-06-30 | −146.65% | +111.96 pp |
| Q1 2022 | 2022-03-31 | −178.17% | +49.71 pp |
| Q4 2021 | 2021-12-31 | −201.30% | +45.50 pp |
| Q3 2021 | 2021-09-30 | −241.06% | −95.20 pp |
| Q2 2021 | 2021-06-30 | −258.61% | −113.05 pp |
| Q1 2021 | 2021-03-31 | −227.88% | −47.84 pp |
| Q4 2020 | 2020-12-31 | −246.80% | −130.87 pp |
| Q3 2020 | 2020-09-30 | −145.86% | +10.19 pp |
| Q2 2020 | 2020-06-30 | −145.56% | +76.36 pp |
| Q1 2020 | 2020-03-31 | −180.04% | +158.52 pp |
| Q4 2019 | 2019-12-31 | −115.93% | +815.17 pp |
| Q3 2019 | 2019-09-30 | −156.06% | — |
| Q2 2019 | 2019-06-30 | −221.92% | — |
| Q1 2019 | 2019-03-31 | −338.57% | — |
| Q4 2018 | 2018-12-31 | −931.09% | — |
| Q2 2013 | 2013-06-30 | −76.99% | — |
| Q4 2011 | 2011-12-31 | −581.75% | — |
| Q3 2011 | 2011-09-30 | −7,951.95% | −7933.69 pp |
| Q2 2011 | 2011-06-30 | −1,024.23% | −1003.95 pp |
| Q1 2011 | 2011-03-31 | −430.61% | — |
| Q3 2010 | 2010-09-30 | −18.26% | — |
| Q2 2010 | 2010-06-30 | −20.28% | — |
Insmed net profit margin trends
Over the last five fiscal years, Insmed's net profit margin decreased from −178.87% to −210.54%, a change of −31.67 percentage points. The latest reported quarter, Q2 2026, shows −3.11%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Insmed source filings ↗Community posts
Insmed raises sales floors as Brinsupri revenue reaches $400 million
Insmed ($INSM) reported third-quarter 2026 revenue of $524.4 million, with Brinsupri contributing $400.1 million, up 29% from the preceding quarter. Arikayce sales increased 9% from a year earlier to $124.4 million, helped by international ...
